Jiutian Chemical Group Limited (SGX:C8R)
Singapore · Delayed Price · Currency is SGD 0.0170
0.00 (0.00%)
At close: Sep 11, 2026
Jiutian Chemical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 81.54 | 109.71 | 50.57 | 598.56 | 2,435 | 2,173 | |
Revenue Growth | 0.81% | 116.96% | -91.55% | -75.42% | 12.03% | 89.60% |
Cost of Revenue | 171.08 | 218.44 | 133.79 | 862.31 | 1,726 | 1,498 |
Gross Profit | -89.54 | -108.72 | -83.22 | -263.75 | 708.41 | 675.62 |
Selling, General & Admin | 25.27 | 26.5 | 30.25 | 49.09 | 62.76 | 58.89 |
Other Operating Expenses | 0.98 | - | - | - | - | - |
Operating Expenses | 29.46 | 29.71 | 23.89 | 49.09 | 62.86 | 65.04 |
Operating Income | -119 | -138.44 | -107.11 | -312.83 | 645.56 | 610.58 |
Interest Expense | -5.48 | -7.39 | -5.75 | -1.98 | -2.3 | -3.67 |
Interest & Investment Income | 2.02 | 3.91 | 8.23 | 15.36 | 15.03 | 5.1 |
Earnings From Equity Investments | -8.53 | -14.78 | -34.12 | -26.5 | 13.14 | -14.56 |
Currency Exchange Gain (Loss) | -3.8 | 0.85 | -0.31 | 5.55 | 5.08 | -3.11 |
Other Non Operating Income (Expenses) | 0.35 | 0.21 | 1.66 | 1.9 | 1.94 | -0.76 |
EBT Excluding Unusual Items | -134.45 | -155.64 | -137.39 | -318.5 | 678.45 | 593.58 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 14.56 |
Gain (Loss) on Sale of Assets | 0.28 | 0.28 | -2.63 | -2.58 | -1.45 | 0.05 |
Asset Writedown | -84.04 | -84.04 | -4.28 | - | - | -3.26 |
Other Unusual Items | - | - | -0.16 | -25.84 | -5 | -120 |
Pretax Income | -218.21 | -239.4 | -144.47 | -346.92 | 671.99 | 485.15 |
Income Tax Expense | 0.23 | 0.23 | 3.43 | -0.2 | 181.62 | 160.66 |
Earnings From Continuing Operations | -218.44 | -239.63 | -147.9 | -346.73 | 490.37 | 324.49 |
Minority Interest in Earnings | - | - | - | 2.09 | 0.12 | 0.41 |
Net Income | -218.44 | -239.63 | -147.9 | -344.64 | 490.5 | 324.9 |
Net Income to Common | -218.44 | -239.63 | -147.9 | -344.64 | 490.5 | 324.9 |
Net Income Growth | - | - | - | - | 50.97% | 87.06% |
Shares Outstanding (Basic) | 1,988 | 1,988 | 1,988 | 1,988 | 1,988 | 1,988 |
Shares Outstanding (Diluted) | 1,988 | 1,988 | 1,988 | 1,988 | 1,988 | 1,988 |
Shares Change | - | - | - | - | - | 7.54% |
EPS (Basic) | -0.11 | -0.12 | -0.07 | -0.17 | 0.25 | 0.16 |
EPS (Diluted) | -0.11 | -0.12 | -0.07 | -0.17 | 0.25 | 0.16 |
EPS Growth | - | - | - | - | 50.97% | 73.95% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -87.5 | -148.12 | -171.63 | -511.23 | 424.05 | 633.54 |
Free Cash Flow Per Share | -0.04 | -0.07 | -0.09 | -0.26 | 0.21 | 0.32 |
Dividend Per Share | - | - | - | 0.048 | 0.046 | 0.022 |
Dividend Growth | - | - | - | 4.12% | 109.04% | - |
Gross Margin | -109.80% | -99.10% | -164.57% | -44.06% | 29.09% | 31.09% |
Operating Margin | -145.93% | -126.18% | -211.81% | -52.26% | 26.51% | 28.09% |
Profit Margin | -267.88% | -218.42% | -292.47% | -57.58% | 20.14% | 14.95% |
Free Cash Flow Margin | -107.30% | -135.00% | -339.41% | -85.41% | 17.42% | 29.15% |
EBITDA | -88.25 | -106.17 | -86.76 | -290.3 | 667.23 | 639.56 |
EBITDA Margin | -108.22% | -96.77% | -171.56% | -48.50% | 27.40% | 29.43% |
D&A For EBITDA | 30.75 | 32.27 | 20.35 | 22.54 | 21.67 | 28.98 |
EBIT | -119 | -138.44 | -107.11 | -312.83 | 645.56 | 610.58 |
EBIT Margin | -145.93% | -126.18% | -211.81% | -52.26% | 26.51% | 28.09% |
Effective Tax Rate | - | - | - | - | 27.03% | 33.12% |